THIS WEBSITE USES COOKIES
We use cookies to personalise content, to provide social media features, and to analyse our traffic. By choosing 'allow all cookies', you consent to our cookies.
To find out more, read our privacy policy and cookie policy.
EU PAL-COPD, a five-year research project funded by Horizon Europe, aims to advance the integration of palliative care in the treatment routine of people with advanced Chronic Obstructive Pulmonary Disease (COPD) in different healthcare systems in Europe.
The project is dedicated to enhancing palliative and end-of-life care for those living with advanced COPD. Through the implementation of a highly innovative non-pharmacological service model called ICLEAR-EU in different healthcare systems in Europe, the goal is to improve not only medical care and physical well-being, but also prioritise a patient-centred and family-centred approach with advance care planning and shared decision-making. In order to successfully implement this palliative care service model into respiratory medicine, the project’s consortium will conduct a clinical trial in 18 hospitals across six European countries. This is the first large-scale international trial systematically integrating palliative care into respiratory care. The ambition of EU PAL-COPD is to improve end-of-life care and well-being of life for millions of COPD patients and their families.
The EU PAL-COPD consortium aims to develop and implement a highly innovative non-pharmacological service model called ICLEAR-EU in different healthcare systems in Europe.
By prioritising a patient-centred and family-centred approach the EU PAL-COPD solution will empower patients as active partners in shared decision-making process.
To implement the palliative care service model into respiratory medicine, the EU PAL-COPD consortium will conduct the first large-scale international clinical trial in 18 hospitals across 6 European countries.
The information you provide will only be used for newsletter campaigns by EU PAL-COPD. We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp’s terms of use. You can unsubscribe at any time by clicking the link in the footer of our emails. Read our privacy policy to learn how your data is used.
EU PAL-COPD is funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or the European Health and Digital Executive Agency (HaDEA). Neither the European Union nor the granting authority can be held responsible for them [grant number 101136621]. This project is also supported by the UK Research and Innovation (UKRI) [grant numbers 10109731 and 10109782], the Ministry of Culture and Innovation of Hungary from the National Research, Development and Innovation Fund [grant number 2020-2.1.1-ED-2023-00260], and the Swiss State Secretariat for Education, Research and Innovation (SERI).
© 2024 accelopment Schweiz AG · info@accelopment.com · ISO 9001 certified · Read our Privacy Policy and Cookie Policy
Stay informed about latest EU PAL-COPD results and milestones.